Timothy Panella, M.D.
Medical Oncology Physician in Knoxville, Tennessee.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Timothy Panella, M.D. reported a CMS MIPS final score of 95.7/100 - above the 83.5 national average - and filed 693 Medicare Part D claims in 2024.
- 95.7/100
- MIPS score · +12 vs avg
- 693
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥78th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Timothy Panella, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1801908223), first enumerated 08/31/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 693 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 95.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.9K in reported industry payments (145 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1801908223 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-ELITE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1801908223
- ENUM-LEGACY 2006
- TAX-NARROW 4,028
- MIPS-ELITE 95.7/100
- RX-LIGHT 693
- BOOK-THIN 82 in Tennessee
- PHOTO-FINISH Guy Tillinghast, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Neil Belman, DO …
Neil Belman, DO
95.6 MIPS pts
- Panella · this p…
Panella · this provider
95.7 MIPS pts
- Guy Tillinghast,…
Guy Tillinghast, M.D.
95.7 MIPS pts
- Brian Vicuna, MD…
Brian Vicuna, MD
95.8 MIPS pts
- Raj Cheruku, MD …
Raj Cheruku, MD
95.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Timothy Panella, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
96 ≥ 78th percentile 78% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Timothy Panella, M.D. sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Timothy Panella, M.D. writes more Part D claims than 64% of them and scores higher on MIPS quality than 83% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Timothy Panella, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Timothy Panella, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Timothy Panella, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Tennessee
How Medical Oncology Physician compares to other specialties among Tennessee providers
Medical Oncology Physician ranks #126 among Tennessee's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Tennessee provider total, by primary NUCC taxonomy. The highlighted bar is Medical Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Timothy Panella, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 95.7/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Medical Oncology Physician US NPIs
95.7/100 MIPS final score - 12.2 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 85.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1801908223 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/31/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Timothy Panella, M.D.'s current license status, disciplinary history, and board certifications with the Tennessee Board of Medical Examiners in Tennessee before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1801908223 is the unique 10-digit identifier CMS uses to link Panella across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Timothy Panella, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Timothy Panella, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.9K
Largest payer
E.R. Squibb & Sons, L.L.C.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,237.567
- Total Day Supply
- 34,698
- Generic Drug Cost
- $17K
- Opioid Claims
- 40 (5.8% rate)
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 2.17
- Gender Split
- 79% female / 21% male
- Age Distribution
- <65: 15, 65-74: 76, 75-84: 65, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Timothy Panella, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Anastrozole
Anastrozole
87 claims
- Tamoxifen Citrate
Tamoxifen Citrate
87 claims
- Levothyroxine Sodium
Levothyroxine Sodium
45 claims
- Eliquis 26
Eliquis
26 claims
- Letrozole 26
Letrozole
26 claims
- Ondansetron Hcl 20
Ondansetron Hcl
20 claims
- Prednisone 20
Prednisone
20 claims
- Kisqali 19
Kisqali
19 claims
| Drug | Claims |
|---|---|
| Anastrozole | 87 |
| Tamoxifen Citrate | 87 |
| Levothyroxine Sodium | 45 |
| Eliquis Apixaban | 26 |
| Letrozole | 26 |
| Ondansetron Hcl | 20 |
| Prednisone | 20 |
| Kisqali Ribociclib Succinate | 19 |
| Exemestane | 17 |
| Verzenio Abemaciclib | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Timothy Panella, M.D. fits within the Medical Oncology Physician landscape nationally.
Timothy Panella, M.D.'s 693 claims are below the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Panella, both outside Tennessee so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (95.7 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Tennessee
Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as Panella.
One of 82 Medical Oncology Physician providers enrolled in Tennessee, 5 are shown here.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Timothy Panella, M.D.'s specialty? ▼
How much does Timothy Panella, M.D. prescribe under Medicare Part D? ▼
What is Timothy Panella, M.D.'s Medicare quality score? ▼
Where is Timothy Panella, M.D. located? ▼
What is Timothy Panella, M.D.'s NPI number? ▼
Does Timothy Panella, M.D. prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does Timothy Panella, M.D. prescribe most often? ▼
Does Timothy Panella, M.D. accept Medicare? ▼
How can I verify Timothy Panella, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.